Login / Signup

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.

David J SullivanKelly A GeboShmuel ShohamEvan M BlochBryan LauAarthi G ShenoyGiselle S MosnaimThomas J GniadekYuriko FukutaBela PatelSonya L HeathAdam C LevineBarry R MeisenbergEmily S SpivakShweta AnjanMoises A HuamanJanis E BlairJudith S CurrierJames H PaxtonJonathan M GerberJoann R PetriniPatrick B BroderickWilliam RauschMarie Elena CordiscoJean HammelBenjamin GreenblattValerie C CluzetDaniel CruserKevin OeiMatthew AbinanteLaura L HammittCatherine G SutcliffeDonald N ForthalMartin S ZandEdward R CachayJay S RavalSeble G KassayeE Colin FosterMichael RothChristi E MarshallAnusha YaravaKaren LaneNichol A McBeeAmy L GawadNicky KarlenAtika SinghDaniel E FordDouglas A JabsLawrence J AppelDavid M ShadeStephan EhrhardtSheriza N BakshOliver LaeyendeckerAndrew S PekoszSabra L KleinArturo CasadevallAaron A R TobianDaniel F Hanley
Published in: medRxiv : the preprint server for health sciences (2021)
ClinicalTrials.gov number, NCT04373460 .
Keyphrases
  • randomized controlled trial
  • coronavirus disease
  • sars cov
  • study protocol
  • combination therapy
  • respiratory syndrome coronavirus
  • replacement therapy
  • meta analyses